Data Bridge Market Research analyses that the cancer diagnostics market is expected to reach the value of USD 28.21 billion by the year 2029, at a CAGR of 7.29% during the forecast period. The rise in the Cancer cases provides growth opportunities to the market

Market Definition

Cancer diagnostics is the process of detecting various biomarkers, proteins, and symptoms that lead to the presence of a cancerous tumour in patients. The detection of specific biomarkers and proteins that are common in cancer disorders leads to the diagnosis process. The process of detecting cancer includes the use of specific technology and devices used in its diagnosis.

 Market Analysis and Size

Cancer has a significant impact on society all over the world. It is one of the leading causes of death worldwide, with a higher prevalence in developed and emerging markets. The alarming rate of rising cancer prevalence compels healthcare providers to reconsider cancer treatment goals and shift their focus to prevention. Cancer diagnostics that are not only specific and sensitive, but also capable of detecting cancer in its early stages would be required.

Get full Access of Sample Report:-https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-cancer-diagnostics-market

Report Scope and Market Segmentation: -

REPORT METRIC

DETAILS

Forecast Period

2022 to 2029

Base Year

2021

Historic Years

2020 (Customizable to 2014 - 2019)

Quantitative Units

Revenue in USD Million, Volumes in Units, Pricing in USD

Segments Covered

Type (Imaging Testing, Biomarkers Testing, In Vitro Diagnostic Testing, Biopsy, Others), Application (Lung Cancer, Breast Cancer, Colorectal Cancer, Melanoma Cancer, Prostate Cancer, Liver Cancer, Others), End-User (Diagnostic Centres, Hospitals and Clinics, Research Institutes, Others)

Countries Covered

U.S., Canada and Mexico in North America, Germany, Sweden, Poland, Denmark, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Global (APAC) in the Global (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America

Market Players Covered

Abbott. (US), DiagnoCure Inc. (Canada), Thermo Fisher Scientific Inc. (US), Illumina, Inc. (US), QIAGEN (Germany), F. Hoffmann-La Roche Ltd (Switzerland), Agilent Technologies, Inc. (US), Quest Diagnostics Incorporated. (US), Merck KGaA, (Germany), Hologic, Inc. (US), BD. (US), GlaxoSmithKline plc. (UK), Novartis AG (Switzerland), Bristol-Myers Squibb Company (US), Eli Lilly and Company (US), Pfizer, Inc. (US), Genomic Health, Inc. (US), bioMérieux SA (France), Astellas Pharma Inc. (Japan) and Myriad Genetics, Inc. (US)

 

COVID-19 Impact on Cancer Diagnostics Market

National lockdowns, government regulations, and an increase in infection rates across countries all had a significant financial impact on neurology hospitals and clinics. Several hospitals and clinics have seen a decrease in patient visits as a result of COVID-19, ultimately reducing client contact. Furthermore, many cancer diagnostics have been pushed back as a result of the COVID-19 crisis. There is a global shortage of medical care for conditions other than COVID-19, which has had a negative impact on the cancer diagnostics market. At the same time, the limited availability of healthcare personnel around the world is another factor that has a negative impact on the cancer diagnostics market.

Recent Development

·        Siemens Healthineers will launch Magnetom Free in November 2021. Star is a low-cost whole-body MRI scanner that is intended to improve global access to magnetic resonance imaging.

·        Agilent Technologies Inc. announced in October 2021 that its PD-L1 IHC 22C3 pharmDx assay has been labelled for use in Triple-Negative Breast Cancer (TNBC) in the European Union.

MAJOR TOC OF THE REPORT

·       Chapter one: Introduction

·       Chapter two: Segmentation

·       Chapter three: Market Definition

Get toc details:-https://www.databridgemarketresearch.com/toc/?dbmr=global-cancer-diagnostics-market

Browse Related Reports

North America Cancer Diagnostics Market

Europe Cancer Diagnostics Market       

Asia-Pacific Cancer Diagnostics Market

About Us:

Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market

Contact:

Data Bridge Market Research

Tel: +1-888-387-2818

Email: Sopan.gedam@databridgemarketresearch.com